Most people don’t contribute to the world over a lifetime what Charlotte Joy Norris did in just two short years. Born with a rare genetic.
KUALA LUMPUR - The Health Ministry (MOH) has approved the registration of Xenpozyme (Olipudase alfa 20mg), to treat patients suffering from Acid Sphingomyelinase Deficiency (ASMD),.
KUALA LUMPUR, Oct 7 The Ministry of Health (MoH) has approved the registration of Xenpozyme (Olipudase alfa 20mg), to treat patients suffering from Acid Sphingomyelinase.
CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - The U.S. Food and Drug Administration approved Genzyme's Xenpozyme (Olipudase alfa) for intravenous infusion in pediatric and adult patients with Acid Sphingomyelinase